Sources of urinary proteins and their analysis by urinary proteomics for the detection of biomarkers of disease

Proteomics - Clinical Applications

Volumn 3, Issue 9, 2009, Pages 1029-1043

  Julian, Bruce A ^a   Suzuki, Hitoshi ^b,c   Suzuki, Yusuke ^c   Tomino, Yasuhiko ^c   Spasovski, Goce ^d   Novak, Jan ^b  

^a University of Alabama at Birmingham   (United States)

^b University of Alabama at Birmingham   (United States)

^c JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d SS CYRIL AND METHODIUS UNIVERSITY OF SKOPJE   (Macedonia)

Author keywords

Glomerular filtration; Nephron; Proteinuria; Renal tubule

Indexed keywords

BIOLOGICAL MARKER;

CAPILLARY ELECTROPHORESIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DISEASE MARKER; GLOMERULOPATHY; GLOMERULUS; GLOMERULUS BASEMENT MEMBRANE; GLOMERULUS FILTRATION RATE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INTERMETHOD COMPARISON; KIDNEY BIOPSY; KIDNEY CORTEX; KIDNEY DISEASE; KIDNEY MEDULLA; KIDNEY STRUCTURE; KIDNEY TUBULE DISORDER; NEPHRON; PRIORITY JOURNAL; PROTEIN URINE LEVEL; PROTEINURIA; PROTEOMICS; REVIEW; SENSITIVITY AND SPECIFICITY; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; TANDEM MASS SPECTROMETRY; TWO DIMENSIONAL GEL ELECTROPHORESIS; URINALYSIS;

EID: 70350776983     PISSN: 18628346     EISSN: None     Source Type: Journal    
DOI: 10.1002/prca.200800243     Document Type: Review

References (161)

1. Briggs, J. P., Kriz, W., Schnermann, J. B. in: Greenberg A. (Eds.), Primer on Kidney Diseases, Elsevier Saunders, Philadelphia 2005, pp. 2-19.
2. Rostgaard, J., Qvortrup, K., Sieve plugs in fenestrae of glomerular capillaries - site of the filtration barrier? Cells Tissues Organs 2002, 170, 132-138.
3. Deen, W. M., Lazzara, M. J., Myers, B. D., Structural determinants of glomerular permeability. Am. J. Physiol. Renal Physiol. 2001, 281, F579-F596.
4. Hassell, J. R., Robey, P. G., Barrach, H. J., Wilczek, J. et al., Isolation of a heparan sulfate-containing proteoglycan from basement membrane. Proc. Natl. Acad. Sci. USA 1980, 77, 4494-4498.
5. Kanwar, Y. S., Linker, A., Farquhar, M. G., Increased permeability of the GBM to ferritin after removal of glycosaminoglycans (heparan sulfate) by enzyme digestion. J. Cell. Biol. 1980, 86, 688-693.
6. Bonsib, S. M. in: Jennette, J. C., Olson, J. L., Schwartz, M. M., Silva, F. G. (Eds.), Heptinstall's Pathology of the Kidney, Lippincott Williams & Wilkins, Philadelphia 2007, pp. 1-70.
7. Barker, D. F., Hostikka, S. L., Zhou, J., Chow, L. T. et al., Identification of mutations in the COL4A5 collagen gene in Alport syndrome. Science 1990, 248, 1224-1227.
8. Hauser, P. V., Collino, F., Bussolati, B., Camussi, G., Nephrin and endothelial injury. Curr. Opin. Nephrol. Hypertens. 2009, 18, 3-8.
9. Mundel, P., Kriz, W., Structure and function of podocytes: an update. Anat. Embryol. (Berl) 1995, 192, 385-397.
10. Shankland, S. J., The podocyte's response to injury: role in proteinuria and glomerulosclerosis. Kidney Int. 2006, 69, 2131-2147.
11. Sever, S., Altintas, M. M., Nankoe, S. R., Moller, C. C. et al., Proteolytic processing of dynamin by cytoplasmic cathepsin L is a mechanism for proteinuric kidney disease. J. Clin. Invest. 2007, 117, 2095-2104.
12. Ronco, P., Proteinuria: is it all in the foot? J. Clin. Invest. 2007, 117, 2079-2082.
13. Wartiovaara, J., Ofverstedt, L. G., Khoshnoodi, J., Zhang, J. et al., Nephrin strands contribute to a porous slit diaphragm scaffold as revealed by electron tomography. J. Clin. Invest. 2004, 114, 1475-1483.
14. Asanuma, K., Yanagida-Asanuma, E., Takagi, M., Kodama, F. et al., The role of podocytes in proteinuria. Nephrology (Carlton) 2007, 12, S15-S20.
15. Kriz, W., Progressive renal failure - inability of podocytes to replicate and the consequences for development of glomerulosclerosis. Nephrol. Dial. Transplant. 1996, 11, 1738-1742.
16. Yu, D., Petermann, A., Kunter, U., Rong, S. et al., Urinary podocyte loss is a more specific marker of ongoing glomerular damage than proteinuria. J. Am. Soc. Nephrol. 2005, 16, 1733-1741.
17. Michael, A. F., The glomerular mesangium. Contrib. Nephrol. 1984, 40, 7-16.
18. Inkyo-Hayasaka, K., Sakai, T., Kobayashi, N., Shirato, I. et al., Three-dimensional analysis of the whole mesangium in the rat. Kidney Int. 1996, 50, 672-683.
19. Mene, P., Simonson, M. S., Dunn, M. J., Physiology of the mesangial cell. Physiol. Rev. 1989, 69, 1347-1424.
20. Ohyama, K., Seyer, J. M., Raghow, R., Kang, A. H., Extracellular matrix phenotype of rat MC in culture. Biosynthesis of collagen types I, III, IV, and V and a low molecular weight collagenous component and their regulation by dexamethasone. J. Lab. Clin. Med. 1990, 116, 219-227.
21. Schlondorff, D., The glomerular mesangial cell: an expanding role for a specialized pericyte. FASEB J. 1987, 1, 272-281.
22. Abboud, H. E., Poptic, E., DiCorleto, P., Production of platelet-derived growth factorlike protein by rat MC in culture. J. Clin. Invest. 1987, 80, 675-683.
23. Aron, D. C., Rosenzweig, J. L., Abboud, H. E., Synthesis and binding of insulin-like growth factor I by human glomerular MC. J. Clin. Endocrinol. Metab. 1989, 68, 585-591.
24. Zoja, C., Wang, J. M., Bettoni, S., Sironi, M. et al., Interleukin-1 b and tumor necrosis factor-a induce gene expression and production of leukocyte chemotactic factors, colony-stimulating factors, and interleukin-6 in human MC. Am. J. Pathol. 1991, 138, 991-1003.
25. Evan, A. P., Gattone, V. H., II, Connors, B. A., Ultrastructural features of the rabbit PT. Arch. Histol. Cytol. 1992, 55, 139-145.
26. Brenner, B. M., Falchuk, K. H., Keimowitz, R. I., Berliner, R. W., The relationship between peritubular capillary protein concentration and fluid reabsorption by the renal proximal tubule. J. Clin. Invest. 1969, 48, 1519-1531.
27. Glassock, R. J. in: Greenberg, A. (Eds.), Primer on Kidney Diseases, Elsevier Saunders, Philadelphia 2005, pp. 36-46.
28. Hsu, H. H., Hoffmann, S., Endlich, N., Velic, A. et al., Mechanisms of angiotensin II signaling on cytoskeleton of podocytes. J. Mol. Med. 2008, 86, 1379-1394.
29. Lai, K. N., Leung, J. C., Chan, L. Y., Saleem, M. A. et al., Podocyte injury induced by mesangial-derived cytokines in IgA nephropathy. Nephrol. Dial. Transplant. 2009, 24, 62-72.
30. Lee, Y. J., Han, H. J., Albumin-stimulated DNA synthesis is mediated by Ca2+/PKC as well as EGF receptor-dependent p44/42 MAPK and NF-kappaB signal pathways in renal proximal tubule cells. Am. J. Physiol. Renal Physiol. 2008, 294, F534-F541.
31. Batuman, V., Proximal tubular injury in myeloma. Contrib. Nephrol. 2007, 153, 87-104.
32. Pote, A., Zwizinski, C., Simon, E. E., Meleg-Smith, S. et al., Cytotoxicity of myeloma light chains in cultured human kidney proximal tubule cells. Am. J. Kidney Dis. 2000, 36, 735-744.
33. Oliver, J., Macdowell, M., Lee, Y. C., Cellular mechanisms of protein metabolism in the nephron. I. The structural aspects of proteinuria; tubular absorption, droplet formation, and the disposal of proteins. J. Exp. Med. 1954, 99, 589-604.
34. Zoja, C., Benigni, A., Remuzzi, G., Cellular responses to protein overload: key event in renal disease progression. Curr. Opin. Nephrol. Hypertens. 2004, 13, 31-37.
35. Schardijn, G. H., Statius van Eps, L. W., Beta 2-microglobulin: its significance in the evaluation of renal function. Kidney Int. 1987, 32, 635-641.
36. Kalluri, R., Proteinuria with and without renal glomerular podocyte effacement. J. Am. Soc. Nephrol. 2006, 17, 2383-2389.
37. Pirani, C. L., Pollak, V. E., Lannigan, R., Folli, G., The renal glomerular lesions of pre-eclampsia: electron microscopic studies. Am. J. Obstet. Gynecol. 1963, 87, 1047-1070.
38. Branten, A. J., van den Born, J., Jansen, J. L., Assmann, K. J. et al., Familial nephropathy differing from minimal change nephropathy and focal glomerulosclerosis. Kidney Int. 2001, 59, 693-701.
39. Nangaku, M., Mechanisms of tubulointerstitial injury in the kidney: final common pathways to end-stage renal failure. Intern. Med. 2004, 43, 9-17.
40. Strutz, F., Muller, G. A., Interstitial pathomechanisms underlying progressive tubulointerstitial damage. Kidney Blood Press. Res. 1999, 22, 71-80.
41. Palmer, B. F., The renal tubule in the progression of chronic renal failure. J. Investig. Med. 1997, 45, 346-361.
42. Pisitkun, T., Shen, R. F., Knepper, M. A., Identification and proteomic profiling of exosomes in human urine. Proc. Natl. Acad. Sci. USA 2004, 101, 13368-13373.
43. Gonzales, P. A., Pisitkun, T., Hoffert, J. D., Tchapyjnikov, D. et al., Large-scale proteomics and phosphoproteomics of urinary exosomes. J. Am. Soc. Nephrol. 2009, 20, 363-379.
44. Zhou, H., Cheruvanky, A., Hu, X., Matsumoto, T. et al., Urinary exosomal transcription factors, a new class of biomarkers for renal disease. Kidney Int. 2008, 74, 613-621.
45. Zhou, H., Pisitkun, T., Aponte, A., Yuen, P. S. et al., Exosomal Fetuin-A identified by proteomics: a novel urinary biomarker for detecting acute kidney injury. Kidney Int. 2006, 70, 1847-1857.
46. Rodby, R. A., Rohde, R. D., Sharon, Z., Pohl, M. A. et al., The urine protein to creatinine ratio as a predictor of 24-hour urine protein excretion in type 1 diabetic patients with nephropathy. The Collaborative Study Group. Am. J. Kidney Dis. 1995, 26, 904-909.
47. Schwab, S. J., Christensen, R. L., Dougherty, K., Klahr, S., Quantitation of proteinuria by the use of protein-to-creatinine ratios in single urine samples. Arch. Intern. Med. 1987, 147, 943-944.
48. Ruggenenti, P., Gaspari, F., Perna, A., Remuzzi, G., Cross sectional longitudinal study of spot morning urine protein:creatinine ratio, 24 hour urine protein excretion rate, glomerular filtration rate, and end stage renal failure in chronic renal disease in patients without diabetes. BMJ 1998, 316, 504-509.
49. Barratt, J., Topham, P., Urine proteomics: the present and future of measuring urinary protein components in disease. CMAJ 2007, 177, 361-368.
50. Hutchison, A. S., O'Reilly, D. S., MacCuish, A. C., Albumin excretion rate, albumin concentration, and albumin/creatinine ratio compared for screening diabetics for slight albuminuria. Clin. Chem. 1988, 34, 2019-2021.
51. Mattix, H. J., Hsu, C. Y., Shaykevich, S., Curhan, G., Use of the albumin/creatinine ratio to detect microalbuminuria: implications of sex and race. J. Am. Soc. Nephrol. 2002, 13, 1034-1039.
52. Hoang, K., Tan, J. C., Derby, G., Blouch, K. L. et al., Determinants of glomerular hypofiltration in aging humans. Kidney Int. 2003, 64, 1417-1424.
53. Dharnidharka, V. R., Kwon, C., Stevens, G., Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis. Am. J. Kidney Dis. 2002, 40, 221-226.
54. Cockcroft, D. W., Gault, M. H., Prediction of creatinine clearance from serum creatinine. Nephron 1976, 16, 31-41.
55. K/DOQI. Clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am. J. Kidney Dis. 2002, 39, S1-S266.
56. Han, W. K., Waikar, S. S., Johnson, A., Betensky, R. A. et al., Urinary biomarkers in the early diagnosis of acute kidney injury. Kidney Int. 2008, 73, 863-869.
57. Mann, J. F., Yi, Q. L., Gerstein, H. C., Albuminuria as a predictor of cardiovascular and renal outcomes in people with known atherosclerotic cardiovascular disease. Kidney Int. 2004, 92, S59-S62.
58. de Jong, P. E., Gansevoort, R. T., Prevention of chronic kidney disease: the next step forward! Nephrology (Carlton) 2006, 11, 240-244.
59. Caramori, M. L., Fioretto, P., Mauer, M., The need for early predictors of diabetic nephropathy risk: is albumin excretion rate sufficient? Diabetes 2000, 49, 1399-1408.
60. Caramori, M., Mauer, M. in: (Eds.), Primer on Kidney Diseases, Elsevier Saunders, Philadelphia 2005, pp. 241-248.
61. Wingo, C. S., Clapp, W. L., Proteinuria: potential causes and approach to evaluation. Am. J. Med. Sci. 2000, 320, 188-194.
62. Yamagata, K., Iseki, K., Nitta, K., Imai, H. et al., Chronic kidney disease perspectives in Japan and the importance of urinalysis screening. Clin. Exp. Nephrol. 2008, 12, 1-8.
63. Palmer, B. F., Proteinuria as a therapeutic target in patients with chronic kidney disease. Am. J. Nephrol. 2007, 27, 287-293.
64. Jafar, T. H., Stark, P. C., Schmid, C. H., Landa, M. et al., Proteinuria as a modifiable risk factor for the progression of non-diabetic renal disease. Kidney Int. 2001, 60, 1131-1140.
65. Zoja, C., Morigi, M., Figliuzzi, M., Bruzzi, I. et al., Proximal tubular cell synthesis and secretion of endothelin-1 on challenge with albumin and other proteins. Am. J. Kidney Dis. 1995, 26, 934-941.
66. Wang, Y., Chen, J., Chen, L., Tay, Y. C. et al., Induction of monocyte chemoattractant protein-1 in proximal tubule cells by urinary protein. J. Am. Soc. Nephrol. 1997, 8, 1537-1545.
67. Zoja, C., Donadelli, R., Colleoni, S., Figliuzzi, M. et al., Protein overload stimulates RANTES production by proximal tubular cells depending on NF-kB activation. Kidney Int. 1998, 53, 1608-1615.
68. Tang, S., Leung, J. C., Abe, K., Chan, K. W. et al., Albumin stimulates interleukin-8 expression in proximal tubular epithelial cells in vitro and in vivo. J. Clin. Invest. 2003, 111, 515-527.
69. Nakajima, H., Takenaka, M., Kaimori, J. Y., Hamano, T. et al., Activation of the signal transducer and activator of transcription signaling pathway in renal proximal tubular cells by albumin. J. Am. Soc. Nephrol. 2004, 15, 276-285.
70. Coppo, R., D'Amico, G., Factors predicting progression of IgA nephropathies. J. Nephrol. 2005, 18, 503-512.
71. D'Amico, G., Bazzi, C., Pathophysiology of proteinuria. Kidney Int. 2003, 63, 809-825.
72. Branten, A. J., Wetzels, J. F., Influence of albumin infusion on the urinary excretion of beta2-microglobulin in patients with proteinuria. Nephron 1999, 81, 329-333.
73. Morigi, M., Buelli, S., Angioletti, S., Zanchi, C. et al., In response to protein load podocytes reorganize cytoskeleton and modulate endothelin-1 gene: implication for permselective dysfunction of chronic nephropathies. Am. J. Pathol. 2005, 166, 1309-1320.
74. Madaio, M. P., Renal biopsy. Kidney Int. 1990, 38, 529-543.
75. Parrish, A. E., Complications of percutaneous renal biopsy: a review of 37 years' experience. Clin. Nephrol. 1992, 38, 135-141.
76. Fliser, D., Novak, J., Thongboonkerd, V., Argilés, À. et al., Advances in urinary proteome analysis and biomarker discovery. J. Am. Soc. Nephrol. 2007, 18, 1057-1071.
77. Hewitt, S. M., Dear, J., Star, R. A., Discovery of protein biomarkers for renal diseases. J. Am. Soc. Nephrol. 2004, 15, 1677-1689.
78. Mischak, H., Apweiler, R., Banks, R. E., Conaway, M. et al., Clinical proteomics: a need to define the field and to begin to set adequate standards. Proteomics Clin. Appl. 2007, 1, 148-156.
79. Goodsaid, F., Bandow, J., Mischak, H., REPORT - Grand Rounds in Proteomics at the FDA (White Oak, Silver Spring, MD, USA, April 3, 2007). Proteomics Clin. Appl. 2007, 1, 1526-1531.
80. HKUPP, 2nd HKUPP Workshop "Towards Standards for Urine Proteomics" (San Francisco, CA, USA, November 1, 2006). 2006.
81. Theodorescu, D., Molecular pathogenesis of urothelial bladder cancer. Histol. Histopathol. 2003, 18, 259-274.
82. Schiffer, E., Mischak, H., Theodorescu, D., Vlahou, A., Challenges of using mass spectrometry as a bladder cancer biomarker discovery platform. World J. Urol. 2008, 26, 67-74.
83. Lee, R. S., Monigatti, F., Briscoe, A. C., Waldon, Z. et al., Optimizing sample handling for urinary proteomics. J. Proteome Res. 2008, 7, 4022-4030.
84. Thongboonkerd, V., Practical points in urinary proteomics. J. Proteome Res. 2007, 6, 3881-3890.
85. Coon, J. J., Syka, J. E., Shabanowitz, J., Hunt, D. F., Tandem mass spectrometry for peptide and protein sequence analysis. Biotechniques 2005, 38, 519-523.
86. Coon, J. J., Ueberheide, B., Syka, J. E., Dryhurst, D. D. et al., Protein identification using sequential ion/ion reactions and tandem mass spectrometry. Proc. Natl. Acad. Sci. USA 2005, 102, 9463-9468.
87. Zubarev, R. A., Kelleher, N. L., McLafferty, F. W., Electron capture dissociation of multiply charged protein cations. A nonergodic process. J. Am. Chem. Soc. 1998, 120, 3265-3266.
88. Farrugia, J. M., O'Hair, R. A. J., Reid, G. E., Do all b(2) ions have oxazolone structures? Multistage mass spectrometry and ab initio studies on protonated N-acyl amino acid methyl ester model systems. Int. J. Mass Spectrom. 2001, 210, 71-87.
89. Valaskovic, G. A., Kelleher, N. L., McLafferty, F. W., Attomole protein characterization by capillary electrophoresis-mass spectrometry. Science 1996, 273, 1199-1202.
90. Reid, G. E., Shang, H., Hogan, J. M., Lee, G. U. et al., Gas-phase concentration, purification, and identification of whole proteins from complex mixtures. J. Am. Chem. Soc. 2002, 124, 7353-7362.
91. Stephenson, J. L., McLuckey, S. A., Reid, G. E., Wells, J. M. et al., Ion/ion chemistry as a top-down approach for protein analysis. Curr. Opin. Biotechnol. 2002, 13, 57-64.
92. Davey, C. A., Sargent, D. F., Luger, K., Maeder, A. W. et al., Solvent mediated interactions in the structure of the nucleosome core particle at 1.9 A resolution. J. Mol. Biol. 2002, 319, 1097-1113.
93. Sze, S. K., Ge, Y., Oh, H., McLafferty, F. W., Top-down mass spectrometry of a 29-kDa protein for characterization of any posttranslational modification to within one residue. Proc. Natl. Acad. Sci. USA 2002, 99, 1774-1779.
94. VerBerkmoes, N. C., Bundy, J. L., Hauser, L., Asano, K. G. et al., Integrating "top-down" and "bottom-up" mass spectrometric approaches for proteomic analysis of Shewanella oneidensis. J. Proteome Res. 2002, 1, 239-252.
95. Hogan, J. M., Pitteri, S. J., McLuckey, S. A., Phosphorylation site identification via ion trap tandem mass spectrometry of whole protein and peptide ions: bovine alpha-crystallin A chain. Anal. Chem. 2003, 75, 6509-6516.
96. He, M., McLuckey, S. A., Charge permutation reactions in tandem mass spectrometry. J. Mass Spectrom. 2004, 39, 1231-1259.
97. Ge, Y., Lawhorn, B. G., ElNaggar, M., Sze, S. K. et al., Detection of four oxidation sites in viral prolyl-4-hydroxylase by top-down mass spectrometry. Protein Sci. 2003, 12, 2320-2326.
98. Ge, Y., Lawhorn, B. G., ElNaggar, M., Strauss, E. et al., Top down characterization of larger proteins (45 kDa) by electron capture dissociation mass spectrometry. J. Am. Chem. Soc. 2002, 124, 672-678.
99. Zabrouskov, V., Giacomelli, L., van Wijk, K. J., McLafferty, F. W., A new approach for plant proteomics: characterization of chloroplast proteins of Arabidopsis thaliana by top-down mass spectrometry. Mol. Cell. Proteomics 2003, 2, 1253-1260.
100. Amunugama, R., Hogan, J. M., Newton, K. A., McLuckey, S. A., Whole protein dissociation in a quadrupole ion trap: identification of an a priori unknown modified protein. Anal. Chem. 2004, 76, 720-727.
101. Newton, K. A., Pitteri, S. J., Laskowski, M., jr., McLuckey, S. A., Effects of single amino acid substitution on the collision-induced dissociation of intact protein ions: Turkey ovomucoid third domain. J. Proteome Res. 2004, 3, 1033-1041.
102. Forbes, A. J., Patrie, S. M., Taylor, G. K., Kim, Y. B. et al., Targeted analysis and discovery of posttranslational modifications in proteins from methanogenic archaea by top-down MS. Proc. Natl. Acad. Sci. USA 2004, 101, 2678-2683.
103. Kelleher, N. L., Top-down proteomics. Anal. Chem. 2004, 76, 197A-203A.
104. Pesavento, J. J., Kim, Y. B., Taylor, G. K., Kelleher, N. L., Shotgun annotation of histone modifications: a new approach for streamlined characterization of proteins by top down mass spectrometry. J. Am. Chem. Soc. 2004, 126, 3386-3387.
105. Geer, L. Y., Markey, S. P., Kowalak, J. A., Wagner, L. et al., Open mass spectrometry search algorithm. J. Proteome Res. 2004, 3, 958-964.
106. Oh, H. B., Lin, C., Hwang, H. Y., Zhai, H. et al., Infrared photodissociation spectroscopy of electrosprayed ions in a Fourier transform mass spectrometer. J. Am. Chem. Soc. 2005, 127, 4076-4083.
107. Coon, J. J., Shabanowitz, J., Hunt, D. F., Syka, J. E., Electron transfer dissociation of peptide anions. J. Am. Soc. Mass Spectrom. 2005, 16, 880-882.
108. Chi, A., Coon, J. J., Syka, J. E. P., Bai, D. et al., Efficient, large-scale phosphoproteome analysis with electron transfer dissociation mass spectrometry. Proceedings of the 53rd ASMS Conference, San Antonio, TX, 2005 2005.
109. Syka, J. E., Coon, J. J., Schroeder, M. J., Shabanowitz, J. et al., Peptide and protein sequence analysis by electron transfer dissociation mass spectrometry. Proc. Natl. Acad. Sci. USA 2004, 101, 9528-9533.
110. Coon, J. J., Syka, J. E. P., Schwartz, J. C., Shabanowitz, J. et al., Anion dependence in the partitioning between proton and electron transfer in ion/ion reactions. Int. J. Mass Spectrom. 2004, 236, 33-42.
111. Renfrow, M. B., MacKay, C. L., Chalmers, M. J., Julian, B. A. et al., Analysis of O-glycan heterogeneity in IgA1 myeloma proteins by Fourier transform ion cyclotron resonance mass spectrometry: implications for IgA nephropathy. Anal. Bioanal. Chem. 2007, 389, 1397-1407.
112. Renfrow, M. B., Cooper, H. J., Tomana, M., Kulhavy, R. et al., Determination of aberrant O-glycosylation in the IgA1 hinge region by electron capture dissociation Fourier transform-ion cyclotron resonance mass spectrometry. J. Biol. Chem. 2005, 280, 19136-19145.
113. Chalmers, M. J., Hakansson, K., Johnson, R., Smith, R. et al., Protein kinase A phosphorylation characterized by tandem Fourier transform ion cyclotron resonance mass spectrometry. Proteomics 2004, 4, 970-981.
114. Håkansson, K., Cooper, H. J., Emmett, M. R., Costello, C. E. et al., Electron capture dissociation and infrared multiphoton dissociation MS/MS of an N-glycosylated tryptic peptic to yield complementary sequence information. Anal. Chem. 2001, 73, 4530-4536.
115. Håkansson, K., Chalmers, M. J., Quinn, J. P., McFarland, M. A. et al., Combined electron capture and infrared multiphoton dissociation for multistage MS/MS in a Fourier transform ion cyclotron resonance mass spectrometer. Anal. Chem. 2003, 75, 3256-3262.
116. Kelleher, R. L., Zubarev, R. A., Bush, K., Furie, B. et al., Localization of labile posttranslational modifications by electron capture dissociation: The case of gamma-carboxyglutamic acid. Anal. Chem. 1999, 71, 4250-4253.
117. Marshall, A. G., Hendrickson, C. L., Jackson, G. S., Fourier transform ion cyclotron resonance mass spectrometry: a primer. Mass Spectrom. Rev. 1998, 17, 1-35.
118. Mirgorodskaya, E., Roepstorff, P., Zubarev, R. A., Localization of O-glycosylation sites in peptides by electron capture dissociation in a Fourier transform mass spectrometer. Anal. Chem. 1999, 71, 4431-4436.
119. Mormann, M., Paulsen, H., Peter-Katalinic, J., Electron capture dissociation of O-glycosylated peptides: radical site-induced fragmentation of glycosidic bonds. Eur. J. Mass Spectrom. 2005, 11, 497-511.
120. Zimmerli, L. U., Schiffer, E., Zurbig, P., Good, D. M. et al., Urinary proteomic biomarkers in coronary artery disease. Mol. Cell. Proteomics 2008, 7, 290-298.
121. Rasmussen, H. H., Orntoft, T. F., Wolf, H., Celis, J. E., Towards a comprehensive database of proteins from the urine of patients with bladder cancer. J. Urol. 1996, 155, 2113-2119.
122. Sarto, C., Deon, C., Doro, G., Hochstrasser, D. F. et al., Contribution of proteomics to the molecular analysis of renal cell carcinoma with an emphasis on manganese superoxide dismutase. Proteomics 2001, 1, 1288-1294.
123. Julian, B. A., Waldo, F. B., Rifai, A., Mestecky, J., IgA nephropathy, the most common glomerulonephritis worldwide. A neglected disease in the United States? Am. J. Med. 1988, 84, 129-132.
124. Wyatt, R. J., Julian, B. A., Bhathena,D. B.,Mitchell, B. L. et al., IgA nephropathy: presentation, clinical course, and prognosis in children and adults. Am. J. Kidney Dis. 1984, 4, 192-200.
125. Berger, J., Hinglais, N., Les depots intercapillaires d'IgA-IgG (intercapillary deposits of IgA-IgG). J. Urol. Nephrol. 1968, 74, 694-695.
126. Jennette, J. C., The immunohistology of IgA nephropathy. Am. J. Kidney Dis. 1988, 12, 348-352.
127. Hiki, Y., Odani, H., Takahashi, M., Yasuda, Y. et al., Mass spectrometry proves under-O-glycosylation of glomerular IgA1 in IgA nephropathy. Kidney Int. 2001, 59, 1077-1085.
128. Allen, A. C., Bailey, E. M., Brenchley, P. E. C., Buck, K. S. et al., Mesangial IgA1 in IgA nephropathy exhibits aberrant O-glycosylation: observations in three patients. Kidney Int. 2001, 60, 969-973.
129. Moldoveanu, Z., Wyatt, R. J., Lee, J., Tomana, M. et al., Patients with IgA nephropathy have increased serum galactose-deficient IgA1 levels. Kidney Int. 2007, 71, 1148-1154.
130. Matousovic, K., Novak, J., Tomana, M., Kulhavy, R. et al., IgA1-containing immune complexes in the urine of IgA nephropathy patients. Nephrol. Dial. Transplant. 2006, 21, 2478-2484.
131. Julian, B. A., Wittke, S., Novak, J., Good, D. M. et al., Electrophoretic methods for analysis of urinary polypeptides in IgA-associated renal diseases. Electrophoresis 2007, 28, 4469-4483.
132. Haubitz, M., Wittke, S., Weissinger, E. M., Walden, M. et al., Urine protein patterns can serve as diagnostic tools in patients with IgA nephropathy. Kidney Int. 2005, 67, 2313-2320.
133. Haubitz, M., Mischak, H., Julian, B. A., Novak, J., Urinary protein patterns as a diagnostic tool in patients with IgA nephropathy. European Renal Disease - Touch Briefings 2009, in press.
134. Good, D. M., Zürbig, P., Bauer, H. W., Behrens, G. et al., Naturally occurring human urinary peptides for use in diagnosis of chronic kidney disease. Mol. Cell. Proteomics 2009, Submitted.
135. Coon, J. J., Zürbig, P., Dakna, M., Dominiczak, A. F. et al., CE-MS analysis of the human urinary proteome for biomarker discovery and disease diagnostics. Proteomics Clin. Appl. 2008, 2, 964-973.
136. Park, M. R., Wang, E. H., Jin, D. C., Cha, J. H. et al., Establishment of a 2-D human urinary proteomic map in IgA nephropathy. Proteomics 2006, 6, 1066-1076.
137. Rocchetti, M. T., Centra, M., Papale, M., Bortone, G. et al., Urine protein profile of IgA nephropathy patients may predict the response to ACE-inhibitor therapy. Proteomics 2008, 8, 206-216.
138. Novak, J., Wittke, S., Haubitz, M., Walden, M. et al., Urinary protein analyses reveal patterns and biomarkers specific for IgA nephropathy (IgAN). J. Am. Soc. Nephrol. 2005, 16, 155.
139. Mischak, H., Julian, B. A., Novak, J., High-resolution proteome/ peptidome analysis of peptides and low-molecular-weight proteins in urine. Proteomics Clin. Appl. 2007, 1, 792-804.
140. Julian, B. A., Wyatt, R. J., Matousovic, K., Moldoveanu, Z. et al., IgA nephropathy: a clinical overview. Contrib. Nephrol. 2007, 157, 19-26.
141. Schiffer, E., Mischak, H., Novak, J., High resolution proteome/peptidome analysis of body fluids by capillary electrophoresis coupled with mass spectrometry. Proteomics 2006, 6, 5615-5627.
142. Galla, J. H., Spotswood, M. F., Harrison, L. A., Mestecky, J., Urinary IgA in IgA nephropathy and Henoch-Schoenlein purpura. J. Clin. Immunol. 1985, 5, 298-306.
143. Halling, S. F. E., Söderberg, M. P., Berg, U. B., Henoch-Schönlein nephritis: clinical findings related to renal function and morphology. Pediatr. Nephrol. 2005, 20, 46-51.
144. Julian, B. A., Wittke, S., Novak, J., Zürbig, P. et al., Urinary polypeptide biomarkers of IgA-associated renal diseases. J. Am. Soc. Nephrol. 2007, 18, 782A.
145. Candiano, G., Musante, L., Bruschi, M., Petretto, A. et al., Repetitive fragmentation products of albumin and a1-antitrypsin in glomerular diseases associated with nephrotic syndrome. J. Am. Soc. Nephrol. 2006, 17, 3139-3148.
146. Rossing, K., Mischak, H., Dakna, M., Zürbig, P. et al., Urinary proteomics in diabetes and CKD. J. Am. Soc. Nephrol. 2008, 19, 1283-1290.
147. Neuhoff, N., Kaiser, T., Wittke, S., Krebs, R. et al., Mass spectrometry for the detection of differentially expressed proteins: a comparison of surface-enhanced laser desorption/ionization and capillary electrophoresis/mass spectrometry. Rapid Commun. Mass Spectrom. 2004, 18, 149-156.
148. Mischak, H., Kaiser, T., Walden, M., Hillmann, M. et al., Proteomic analysis for the assessment of diabetic renal damage in humans. Clin. Sci. (Lond) 2004, 107, 485-495.
149. Kolch, W., Neus. uss, C., Pelzing, M., Mischak, H., Capillary electrophoresis-mass spectrometry as a powerful tool in clinical diagnosis and biomarker discovery. Mass Spectrom. Rev. 2005, 24, 959-977.
150. Otu, H. H., Can, H., Spentzos, D., Nelson, R. G. et al., Prediction of diabetic nephropathy using urine proteomic profiling 10 years prior to development of nephropathy. Diabetes Care 2007, 30, 638-643.
151. Schlessinger, S. D., Tankersley, M. R., Curtis, J. J., Clinical documentation of end-stage renal disease due to hypertension. Am. J. Kidney Dis. 1994, 23, 655-660.
152. Wolfe, R. A., Ashby, V. B., Milford, E. L., Ojo, A. O. et al., Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N. Engl. J. Med. 1999, 341, 1725-1730.
153. Ivanyi, B., A primer on recurrent and de novo glomerulonephritis in renal allografts. Nat. Clin. Pract. Nephrol. 2008, 4, 446-457.
154. Clarke, W., Silverman, B. C., Zhang, Z., Chan, D. W. et al., Characterization of renal allograft rejection by urinary proteomic analysis. Ann. Surg. 2003, 237, 660-664; discussion 664-665.
155. Wittke, S., Haubitz, M., Walden, M., Rohde, F. et al., Detection of acute tubulointerstitial rejection by proteomic analysis of urinary samples in renal transplant recipients. Am. J. Transplant. 2005, 5, 2479-2488.
156. Schaub, S., Rush, D., Wilkins, J., Gibson, I. W. et al., Proteomic-based detection of urine proteins associated with acute renal allograft rejection. J. Am. Soc. Nephrol. 2004, 15, 219-227.
157. Schaub, S., Wilkins, J. A., Nickerson, P., Proteomics and renal transplantation: searching for novel biomarkers and therapeutic targets. Contrib. Nephrol. 2008, 160, 65-75.
158. Trocme, C., Marotte, H., Baillet, A., Pallot-Prades, B. et al., Apolipoprotein A-I and platelet factor 4 are biomarkers for Infliximab response in rheumatoid arthritis. Ann. Rheum. Dis. 2009, in press, PMID: 18664547.
159. Zhang, X., Jin, M., Wu, H., Nadasdy, T. et al., Biomarkers of lupus nephritis determined by serial urine proteomics. Kidney Int. 2008, 74, 799-807.
160. Domon, B., Aebersold, R., Mass spectrometry and protein analysis. Science 2006, 312, 212-217.
161. Rifai, N., Gillette, M. A., Carr, S. A., Protein biomarker discovery and validation: the long and uncertain path to clinical utility. Nat. Biotechnol. 2006, 24, 971-983.